132.55 USD
↘ 0.13 (0.10%)AT CLOSE (11:59 AM EDT)
Apogee Therapeutics, Inc. Common Stock
APGENASDAQ • USD
132.56
↗ 0.01 (0.01%)
POST MARKET (AS OF 07:23 PM EDT)
Post Market
AS OF 07:23 PM EDT
132.56
↗ 0.01 (0.01%)
Market: CLOSED
Shares of Apogee Therapeutics, Inc. Common Stock (APGE) are trading at $132.55. APGE shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. APGE is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$132.75
High?$132.87
Low?$132.55
Prev. Close?$132.68
Volume?5.1M
Avg. Volume?3.9M
VWAP?$132.67
Rel. Volume?1.30x
Bid / Ask
Bid?$132.56 × 1.0K
Ask?$134.99 × 100
Spread?$2.43
Midpoint?$133.78
Valuation & Ratios
Market Cap?10.0B
Shares Out?61.9M
Float?48.8M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?7.94
EPS?-$3.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Employees
261
Market Cap
10.0B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-07-14
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: 650-394-5230
WALTHAM, MA 02453
Phone: 650-394-5230
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?157.43Safe
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?21.45%Squeeze Risk
Short Interest?10.5M
Days to Cover?10.3
Free Float48.8M
Avg Daily Volume1.0M
Settlement Date2026-06-15
Financial Health
Current Ratio?32.59Strong
Quick Ratio?32.59Strong
Cash Ratio?13.71Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?7.94FAIR▾
Peers100
S&P24
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-31.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-21.9%WEAK▾
S&P7
ROA?-21.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-235373000
Enterprise Value?$9.5B
Fundamentals ratios updated end of day